Old Web
English
Sign In
Acemap
>
authorDetail
>
Brad M. Haverkos
Brad M. Haverkos
Ohio State University
Oncology
relapsed refractory
Internal medicine
Medicine
multi center study
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study
2021
Blood
Swaminathan P. Iyer
Auris Huen
Weiyun Z. Ai
Deepa Jagadeesh
Mary Jo Lechowicz
Craig Okada
Tatyana Feldman
Suchitra Sundaram
Juan Pablo Alderuccio
Nishitha Reddy
Don A. Stevens
Timothy M. Kuzel
Ann Mohrbacher
Kasi V. Routhu
Prajak J. Barde
Ajit Nair
Brad M. Haverkos
Show All
Source
Cite
Save
Citations (0)
Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving CAR-T Cell Therapy
2021
Blood
Gray Jodon
Meryl Colton
Diana Abbott
Anthony Cai
Brad M. Haverkos
Rustain Morgan
Manali Kamdar
Show All
Source
Cite
Save
Citations (0)
1